Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Design and Rationale of the COLT Study: a Multicentre, Randomised, Double-blind, Placebo-controlled Trial of COLchicine as Adjunctive Therapy to Standard Anticoagulation in Acute Proximal Deep Vein Thrombosis of the Lower Limbs

NCT07432529 is registered in ClinicalTrials.gov with Azienda Sanitaria Locale ASL 6, Livorno as lead sponsor.

NCT NCT07432529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07432529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Design and Rationale of the COLT Study: a Multicentre, Randomised, Double-blind, Placebo-controlled Trial of COLchicine as Adjunctive Therapy to Standard Anticoagulation in Acute Proximal Deep Vein Thrombosis of the Lower Limbs
Lead sponsor
Azienda Sanitaria Locale ASL 6, Livorno
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
June 1, 2027
Enrollment
940 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post-thrombotic syndrome, venous insufficiency, venous thromboembolism (vte), venous thrombosis deep (limbs)